Journal of Psychoactive Drugs

Papers
(The TQCC of Journal of Psychoactive Drugs is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Decisional Balance of Smoking and Planning to Quit Smoking: A Moderated Mediation Model among Chinese Male Smokers67
Multidimensional Acculturation, Acculturative Stress and Alcohol or Drug Use of Adult Latinx Immigrants47
Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015–202042
The Differential Contribution of Adverse Childhood Experiences and Perceived Discrimination on Substance Use among Hispanic Emerging Adults28
Methamphetamine-Induced Wakefulness and Sleep Management: A Qualitative Analysis of Online Narratives28
Prevalence and Correlates of GHB Use among Adults in the United States28
Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies24
Cannabis for Healing in a Native Community Clinic: Development and Results from an Informatics Research Tool22
Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health18
Psychedelic Experiences and Mindfulness are Associated with Improved Wellbeing18
Impact of a Naturalistic Psychedelic Experience on Smoking: A Retrospective Survey17
The Epidemiology of Psychedelic Use Among United States Military Veterans16
Survey of U.S. Residents and Their Usage of Electronic Cigarettes with Drugs Other Than Nicotine15
Exploring the Role of Traumatic Event Exposure in Tobacco Dependence Treatment Outcomes Among African Americans15
Harm Reduction Strategies among University Students Who Use Alcohol and Cannabis, and Related Psychological Variables: A Systematic Review14
Construction and Standardization of Perceived Shame Scale for Young Adults with Paternal Substance Use Disorder in Pakistan14
Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders14
Inhaled Dimethyltryptamine (DMT): Use Patterns and Predictors of Consumption Frequency13
“It’s so Natural It Goes Hand in Hand”: A Qualitative Study of Maternal Perceptions of Cannabis Use during Pregnancy12
Religion, Psychedelics, Risky Behavior, and Violence12
A Meta-Analysis of Functional Neuroimaging Studies of Ketamine Administration in Healthy Volunteers12
Suicide Attempts in an Italian Population with Cannabis Use Disorders: Results of a Follow-Up Study11
Naturalistic Psychedelic Use: A World Apart from Clinical Care10
Language Brokering–Stress Transition Profiles and Marijuana Use in Mexican-Origin Adolescents10
Prescription and Non-Prescription Anxiolytic Use is Linked to Personal Characteristics Among University Students10
Comparison of Emotional Processing Between Patients with Substance Use Disorder and Those with Dual Diagnosis: Relationship with Severity of Dependence and Use During Treatment10
Experimental Test of Perceptions of Psychedelics by Therapeutic and Recreational Use10
Religious Social Integration, Psychedelics, and Psychological Distress10
Interactions Between Depressive Symptoms, Childhood Trauma, and Drug Craving in Chinese Men with Methamphetamine Use Disorder: A Network Analysis10
A Cross-Sectional Survey Investigating Māori and Non-Māori Cancer Patients’ Views on Psychedelic-Assisted Therapy in Aotearoa New Zealand9
Psychedelic Microdosing among Young Adults from Southern California9
Self-Forgiveness and Gratitude in Recovery from Substance Use Disorders9
Smoking Behavior and Wellness among Individuals in Substance Use Disorder Treatment8
Spiritual Benefit from Cannabis8
Atypical Neuroleptic Malignant Syndrome: Case Reports and Diagnostic Challenges8
The Potential Impact of Legalization of Recreational Cannabis among Current Users: A Qualitative Inquiry8
Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey8
Not Losing Momentum: Cross-Sectional Insights into Ibogaine Clinical Trials7
Psychedelic Research and Therapeutic Practices: Embracing Communities, Groups, and Traditional Knowledge7
State-Level Support for Recovery Housing: Results from a National Collaborative Study of U.S. Single State Agencies7
Effect of Social Vulnerability on Cocaine-Related Mortality Rates in U.S. Counties7
Going Underground: Demographics, Services, and Best Practices Endorsed by Practitioners Providing Support for Naturalistic Psychedelic Use7
Associations Between Ayahuasca Use in Naturalistic Settings and Mental Health and Wellbeing Outcomes: Analysis of a Large Global Dataset7
“Spice Was Made, by the Devil Himself”: A Thematic Analysis of the Experience of an Addiction to Synthetic Cannabinoids7
Psychedelic Use and Behavioral Addictions7
Solitary Cannabis Use and Related Consequences Among College Students During the COVID-19 Pandemic7
N, N-Dimethyltryptamine (DMT)-Occasioned Familiarity and the Sense of Familiarity Questionnaire (SOF-Q)7
Vermont Primary Care Provider Perspectives on Psychedelics — A Cross-Sectional Study6
Exposure to Secondhand Smoke at Home and Psychological Distress among College Students in China: The Role of Parental Attachment6
Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing Study6
Acculturation Style Is Associated with Stress and Tobacco Use among East African Immigrants6
Delta-8- and Delta-9-THC Use Frequency, Use Motives, and Mental Health Outcomes6
Therapeutic Protocols Using Ketamine and Esketamine for Depressive Disorders: A Systematic Review6
A Nationwide Study Comparing Mental Health Professionals’ Willingness to Try Hallucinogenic Drugs in Basic Research or Clinical Practice6
Does the Perception of Risk Associated with Psychedelics Use Differ in Physicians According to Their Belief of Effectiveness?6
Differences in Online Descriptions and Marketing of Derived Intoxicating Cannabis Products6
Opioid Use Disorder and COVID-19: Treatment and Recovery Factors among Vulnerable Populations at the Intersection of Two U.S. Epidemics6
Ayahuasca Ritual, Personality and Sociality: Observational Research Conducted in a Substance Use Disorder Rehabilitation Center in Uruguay6
Outcomes Among Sober Living House Residents Who Relapse: Role of Recovery Capital6
Advancing Health Equity through Substance Use Research6
Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences5
Kratom Retail Availability in Fort Worth, Texas5
Identification of Cannabis Product Characteristics and Pricing on Dark Web Markets5
The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment – A Pilot Study5
Approach Without Liking: The Effects of Smoking-Related Settings on Implicit Liking Attitudes and Approach Tendencies Toward Smoking5
Determinants of Relapse and Opportunities for Growth: Perspectives on Substance Use among American Indian Community Members5
Cannabis Consumption Onset and Addiction: Data from the Second Brazilian Drugs and Alcohol Survey (BNADS)5
Healing Words: Effects of Psychoeducation on Likelihood to Seek and Refer Psychedelic-Assisted Psychotherapy Among BIPOC Individuals5
What Differentiates Dropping Out from Remaining in a Brief Intervention for Problematic and Dependent Methamphetamine Users?5
A Psychonaut’s Experience of Intoxication with Multiple Classes of Drugs Including Novel Psychoactive Substance 2-fluorodeschloroketamine: Case Report and Urinary Analysis4
Ayahuasca, Personality and Acute Psychological Effects in Neo-Shamanic and Religious Settings in Uruguay4
Examining Predictors of Nicotine Dependence in Korean Adolescents : Comparing Ever Quitters and Never Quitters4
O-Know Opioid Knowledge Test: Development and Psychometric Testing in a Community Setting4
Self-reported Impact of the COVID-19 Pandemic on Cannabis Use in Canada and the United States4
Therapeutic Potential of Psychedelics for Treating Anosmia: An Investigation of Online Accounts4
Prevalence of Substance Use Among Asian Sexual Minority Individuals in the United States, 2015-20204
“How Do I Learn More About this?”: Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics4
Cannabis Dependence Among Georgian Small-Scale Cannabis Growers: Results of a Cross-Sectional Online Survey4
Death Anxiety Among Users and Non-Users of Psychedelics4
The Role of Parental Involvement in Cigarette Smoking among Adolescents in Nepal4
Building Capacity for Injectable Diacetylmorphine and Hydromorphone for the Treatment of Opioid Use Disorder: Identifying Typical Doses4
Effects of Psychedelic Use on Racial Trauma Symptoms and Ethnic Identity among Asians in North America4
Driving Under the Influence of Alcohol, Cannabis, and Delta-8 THC: Perceived Likelihood, Risk Perceptions, and Behaviors4
Rapid Effects of MDMA Administration on Self-Reported Personality Traits and Affect State: A Randomized, Placebo-Controlled Trial in Healthy Adults4
The Complexity of Impulsivity Dimensions among Abstinent Individuals with Substance Use Disorders4
Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia4
Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts4
Psychedelic Treatments for Substance Use Disorder and Substance Misuse: A Mixed Methods Systematic Review4
Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption4
Psilocybin’s Potential Mechanisms in the Treatment of Depression: A Systematic Review4
Sweating for Sobriety: Exploring the Relationship Between Exercise Engagement and Substance Use Disorders4
Weeding Out the Stigma: Older Veterans in Illinois Share Their Experiences Using Medical Cannabis4
In Memoriam: Roland R. Griffiths (July 19, 1946–October 16, 2023)4
Chemsex and Harm Reduction Practices Among Men Who Have Sex with Men in Malaysia: Findings from a Qualitative Study4
Public Knowledge, Perceptions, and Behavioral Intention Regarding Medical Cannabis in Belgium4
Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine4
Therapeutic Effects of Ceremonial Ayahuasca Use for Methamphetamine Use Disorders and Other Mental Health Challenges: Case Studies in an Indigenous Community in Sonora, Mexico4
0.081492900848389